Skip to main content
. Author manuscript; available in PMC: 2013 Jun 15.
Published in final edited form as: J Surg Res. 2011 Apr 22;175(2):234–242. doi: 10.1016/j.jss.2011.03.069

Table 1.

Effect of NaHS (10−3 M) on spontaneous and stimulated contractile activity (after precontraction with bethanechol (3×10−6 M)) without and with antagonists of pathways potentially involved in the HsS effect

Antagonist Effect on spontaneous
contractile activity
Effect on stimulated contractile
activity
Control
response to
NaHS
Response
to NaHS
with
antagonist
p Control
response
to NaHS
Response
to NaHS
with
antagonist
p
NANC
conditions
−47±14 −74±14 * <0.02 - - -
TTX −34±12 −81±8 * <0.01 −62±7 −74±3 * <0.05
Capsaicin −34±12 −66±12 * <0.01 −62±7 −69±8 0.09
L-NNA −53±10 −77±10 * <0.03 −69±9 −80±5 * <0.01
Glibenclamide −53±10 −68±6 0.23 −69±9 −42±7 * <0.01

Percent change from baseline contractile activity; x±SEM; n=8 rats

*

Differs from control response under same condition (spontaneous or stimulated contractile activity; ANOVA)

NANC: non-adrenergic, non-cholinergic

TTX: tetrodotoxin

L-NNA: L-NG-nitro arginine